Literature DB >> 3924370

Hypercalciuria during experimental vitamin K deficiency in the rat.

D Robert, V Jorgetti, B Lacour, M Leclerq, G Cournot-Witmer, A Ulmann, T Drüeke.   

Abstract

Vitamin K promotes the formation of gamma-carboxylated glutamate (GLA) in several protein species. GLA residues have a high affinity for the Ca ion. In the present study, we tested the hypothesis that experimental vitamin K deficiency in rats could induce changes in Ca metabolism. Vitamin K depletion, which was associated with a reduction in urinary GLA excretion, induced within 7 days a significant increase in cumulative urinary Ca excretion that persisted throughout the 21 days of study. The hypercalciuria of vitamin K-deficient rats was corrected on vitamin K supplementation. No concomitant changes were observed in intestinal Ca absorption determined by a balance technic or of skeletal resorption and apposition rates determined by bone histomorphometry. Plasma Ca, but not total protein concentration, of vitamin k-depleted rats showed a transient decrease at day 15 that disappeared at day 21. plasma sodium, phosphate and 1,25(OH)2 vitamin D concentration, and urinary phosphate, sodium, and creatinine excretion remained unchanged. In conclusion, vitamin k deficiency in the rat induced hypercalciuria that could be of renal origin. Its possible relationship to vitamin K-dependent renal GLA protein remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924370     DOI: 10.1007/bf02554833

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  21 in total

1.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma.

Authors:  J A Eisman; A J Hamstra; B E Kream; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1976-09       Impact factor: 4.013

2.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

3.  Quantitative determination of gamma-carboxyglutamic acid in proteins.

Authors:  P V Hauschka
Journal:  Anal Biochem       Date:  1977-05-15       Impact factor: 3.365

4.  Some characteristics of a vitamin K-dependent carboxylating system from rat liver microsomes.

Authors:  P A Friedman; M Shia
Journal:  Biochem Biophys Res Commun       Date:  1976-05-17       Impact factor: 3.575

Review 5.  Vitamin K-dependent formation of gamma-carboxyglutamic acid.

Authors:  J Stenflo; J W Suttie
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

6.  gamma-Carboxyglutamic acid in human urine.

Authors:  P Fernlund
Journal:  Clin Chim Acta       Date:  1976-10-01       Impact factor: 3.786

7.  gamma-Carboxyglutamate excretion and warfarin therapy.

Authors:  R J Levy; J B Lian
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

8.  gamma-Carboxyglutamic acid-containing protein of rat kidney cortex. Changes with high fat diet, and molecular parameters.

Authors:  Z Deyl; C Vancíková; K Macek
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-12

9.  Interactions of vitamin K-dependent proteins with calcium ions and phospholipid membranes.

Authors:  G L Nelsestuen
Journal:  Fed Proc       Date:  1978-10

10.  The vitamin K-dependent synthesis of gamma-carboxyglutamic acid by bone microsomes.

Authors:  J B Lian; P A Friedman
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

View more
  2 in total

1.  The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.

Authors:  E M Worcester; J L Sebastian; J G Hiatt; A M Beshensky; J A Sadowski
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

2.  Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.